tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lantheus: Strong Q3 Performance and Pylarify 2.0 Drive Buy Rating with $70 Target
PremiumRatingsLantheus: Strong Q3 Performance and Pylarify 2.0 Drive Buy Rating with $70 Target
15d ago
Lantheus announces CEO Markison to retire, Heino appointed as interim CEO
Premium
The Fly
Lantheus announces CEO Markison to retire, Heino appointed as interim CEO
15d ago
Lantheus Announces CEO Retirement and Leadership Transition
Premium
Company Announcements
Lantheus Announces CEO Retirement and Leadership Transition
15d ago
Lantheus announces FDA established PDUFA date for LNTH-2501
PremiumThe FlyLantheus announces FDA established PDUFA date for LNTH-2501
22d ago
Lantheus announces FDA acceptance of NDA for MK-6240
Premium
The Fly
Lantheus announces FDA acceptance of NDA for MK-6240
24d ago
Radiopharm launches A$5M share purchase plan
Premium
The Fly
Radiopharm launches A$5M share purchase plan
1M ago
Lantheus price target lowered to $84 from $109 at B. Riley
PremiumThe FlyLantheus price target lowered to $84 from $109 at B. Riley
2M ago
Lantheus price target lowered to $80 from $95 at TD Cowen
Premium
The Fly
Lantheus price target lowered to $80 from $95 at TD Cowen
2M ago
Lantheus Faces Legal Heat Over Misleading Projections
Premium
Class Action
Lantheus Faces Legal Heat Over Misleading Projections
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100